Psychedelic Assisted Therapies for Mental Illness – Webinar for PACFA Members – 25th August 2021



FREE WEBINAR: Psychedelic Assisted Therapies for Mental Illness – Webinar for PACFA Members.

This is a recording from our webinar on 25th August 2021.

Learn more about Mind Medicine Australia on our website: https://mindmedicineaustralia.org​

——————

Our speakers:

• Dr Nigel Denning, Counselling Psychologist, AHPRA registered supervisor and Managing Director of Integrative Psychology a Psychology/Psychiatry practice in East Melbourne.

• Tania de Jong AM, Co-Founder and Executive Director Mind Medicine Australia, Creativity Australia, Creative Universe and The Song Room

Pre-Covid 1 in 5 people in Australia were suffering from a mental illness. At least 1 in 8 adults, 1 in 4 older adults in 1 in 30 children are on anti-depressant medications currently, and often without disclosure of potential side effects. There has been no innovation in existing treatments for 5 decades. The lack of effective treatments has most certainly contributed to Australia’s devastating mental health statistics, which position Australia as second worst amongst all OECD nations, only ahead of Iceland. As a result of the Covid-19 pandemic many more Australians are experiencing anxiety, trauma, addiction, depression, loneliness and social isolation, and suicide rates could significantly increase in the absence of innovation in treatments.

In the quest for new treatment options for mental illness and psychiatric disorders, attention is being paid to the potential role of psychedelic medicines as adjuncts to psychotherapy for a wide array of conditions, including depression, anxiety, post-traumatic stress disorder and some addictions. Trials are also underway for dementia, Parkinson’s, strokes, cluster headaches, OCD and eating disorders. A proactive approach to broadening the treatment options available for people who have a mental illness is desperately needed.

This keynote and Q & A Session is presented by Mind Medicine Australia. The session will provide an engaging and educational update incorporating new learnings, science and data about innovative, safe and effective treatments being used in a practical clinical setting. It will also provide information on how to access the TGA’s SAS-B pathway for psilocybin and MDMA assisted therapies for treatment-resistant patients on a case-by-case basis.

——————

Mind Medicine Australia is a charity that enables the development of regulatory-approved and research-backed medicine-assisted psychotherapy for the treatment of mental ill-health in Australia.

——————

Learn more about Mind Medicine Australia on our website: https://buff.ly/2W4xe62​

Follow us on social media:

Facebook: https://buff.ly/3fGeLU5​
Twitter: https://buff.ly/2UVNaWW​
Instagram: https://buff.ly/2Y9ijIu​
LinkedIn: https://buff.ly/2YL2Zkj

Source: Youtube